Literature DB >> 29128936

Hospital time prior to death and pancreas histopathology: implications for future studies.

Irina Kusmartseva1, Maria Beery1, Tiffany Philips1, Stephen Selman1, Priyanka Jadhav1, Clive Wasserfall1, Axel Muller2, Alberto Pugliese3,4, Jeffrey A Longmate5, Desmond A Schatz1,6, Mark A Atkinson1,6, John S Kaddis7.   

Abstract

AIMS/HYPOTHESIS: Diabetes research studies routinely rely upon the use of tissue samples from human organ donors. It remains unclear whether the length of hospital stay prior to organ donation affects the presence of cells infiltrating the pancreas or the frequency of replicating beta cells.
METHODS: To address this, 39 organ donors without diabetes were matched for age, sex, BMI and ethnicity in groups of three. Within each group, donors varied by length of hospital stay immediately prior to organ donation (<3 days, 3 to <6 days, or ≥6 days). Serial sections from tissue blocks in the pancreas head, body and tail regions were immunohistochemically double stained for insulin and CD45, CD68, or Ki67. Slides were electronically scanned and quantitatively analysed for cell positivity.
RESULTS: No differences in CD45+, CD68+, insulin+, Ki67+ or Ki67+/insulin+ cell frequencies were found when donors were grouped according to duration of hospital stay. Likewise, no interactions were observed between hospitalisation group and pancreas region, age, or both; however, with Ki67 staining, cell frequencies were greater in the body vs the tail region of the pancreas (∆ 0.65 [unadjusted 95% CI 0.25, 1.04]; p = 0.002) from donors <12 year of age. Interestingly, frequencies were less in the body vs tail region of the pancreas for both CD45+ cells (∆ -0.91 [95% CI -1.71, -0.10]; p = 0.024) and insulin+ cells (∆ -0.72 [95% CI -1.10, -0.34]; p < 0.001). CONCLUSIONS/
INTERPRETATION: This study suggests that immune or replicating beta cell frequencies are not affected by the length of hospital stay prior to donor death in pancreases used for research. DATA AVAILABILITY: All referenced macros (adopted and developed), calculations, programming code and numerical dataset files (including individual-level donor data) are freely available on GitHub through Zenodo at https://doi.org/10.5281/zenodo.1034422.

Entities:  

Keywords:  Basic science; Clinical science; Human; Imaging (MRI/PET/other); Islets; Islets(all); Pathophysiology/metabolism

Mesh:

Substances:

Year:  2017        PMID: 29128936      PMCID: PMC5844815          DOI: 10.1007/s00125-017-4494-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Factors That Influence the Quality of RNA From the Pancreas of Organ Donors.

Authors:  Tiffany Philips; Irina Kusmartseva; Ivan C Gerling; Martha Campbell-Thompson; Clive Wasserfall; Alberto Pugliese; Jeffrey A Longmate; Desmond A Schatz; Mark A Atkinson; John S Kaddis
Journal:  Pancreas       Date:  2017-02       Impact factor: 3.327

2.  β Cells Persist in T1D Pancreata Without Evidence of Ongoing β-Cell Turnover or Neogenesis.

Authors:  Carol J Lam; Daniel R Jacobson; Matthew M Rankin; Aaron R Cox; Jake A Kushner
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

3.  Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.

Authors:  J S Kaddis; J S Danobeitia; J C Niland; T Stiller; L A Fernandez
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

4.  Beta-cell replication is increased in donor organs from young patients after prolonged life support.

Authors:  Peter In't Veld; Neelke De Munck; Kristien Van Belle; Nicole Buelens; Zhidong Ling; Ilse Weets; Patrick Haentjens; Miriam Pipeleers-Marichal; Frans Gorus; Daniel Pipeleers
Journal:  Diabetes       Date:  2010-04-22       Impact factor: 9.461

5.  Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.

Authors:  Juris J Meier; Alexandra E Butler; Yoshifumi Saisho; Travis Monchamp; Ryan Galasso; Anil Bhushan; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2008-03-11       Impact factor: 9.461

6.  Human pancreatic islets and diabetes research.

Authors:  John S Kaddis; Barbara J Olack; Janice Sowinski; James Cravens; Juan L Contreras; Joyce C Niland
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Regional differences in islet distribution in the human pancreas--preferential beta-cell loss in the head region in patients with type 2 diabetes.

Authors:  Xiaojun Wang; Ryosuke Misawa; Mark C Zielinski; Peter Cowen; Junghyo Jo; Vipul Periwal; Camillo Ricordi; Aisha Khan; Joel Szust; Junhui Shen; J Michael Millis; Piotr Witkowski; Manami Hara
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

Review 8.  Immune modulation in humans: implications for type 1 diabetes mellitus.

Authors:  Bart O Roep; Timothy I M Tree
Journal:  Nat Rev Endocrinol       Date:  2014-01-28       Impact factor: 43.330

9.  Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes.

Authors:  Teresa Rodriguez-Calvo; Olov Ekwall; Natalie Amirian; Jose Zapardiel-Gonzalo; Matthias G von Herrath
Journal:  Diabetes       Date:  2014-06-19       Impact factor: 9.461

10.  Stereological analyses of the whole human pancreas.

Authors:  Ananta Poudel; Jonas L Fowler; Mark C Zielinski; German Kilimnik; Manami Hara
Journal:  Sci Rep       Date:  2016-09-23       Impact factor: 4.379

View more
  2 in total

Review 1.  β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.

Authors:  Teresa Mezza; Francesca Cinti; Chiara Maria Assunta Cefalo; Alfredo Pontecorvi; Rohit N Kulkarni; Andrea Giaccari
Journal:  Diabetes       Date:  2019-06       Impact factor: 9.461

2.  Quantification of pancreatic proton density fat fraction in diabetic pigs using MR imaging and IDEAL-IQ sequence.

Authors:  Yidi Chen; Liling Long; Zijian Jiang; Ling Zhang; Delin Zhong; Xialing Huang
Journal:  BMC Med Imaging       Date:  2019-05-14       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.